Urinary Tract Infection Devices Market

The Urinary Tract Infection Testing Market By Test Type (Urinalysis, Urine Cultures, And Susceptibility Testing), Product Type (Instruments And Kits [Laboratory Test Kits And Home Test Kits), End-User (Hospitals, Diagnostic Labs, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing number of people with cardiovascular diseases (CVDS) and growing incidence of hospital-acquired urinary tract infection

The global urinary tract infection testing market was valued at USD 607.20 million in 2023, growing at a CAGR of 5.67% during the forecast period from 2024 to 2030 to reach USD 893.11 million by 2030. The demand for urinary tract infection testing is primarily being boosted by the rising number of cases of urinary tract infections (UTI) globally, the growing incidence of hospital-acquired urinary tract infection, and increasing preference for at-home and self-testing kits for early diagnosis of UTI among others. Furthermore, the urinary tract infection testing market is anticipated to grow on account of a large number of ongoing research activities in this field, collaborations between healthcare providers, researchers, and industry players, and strategic partnerships among others are going to contribute to the overall growth of the urinary tract infection testing market during the forecast period from 2024-2030. 

Urinary Tract Infection Testing Market Dynamics:

An infection of the urinary tract is known as a urinary tract infection, or UTI. The bladder, kidneys, ureters, and urethra are just a few of the urinary system locations where the infection may strike.

The symptoms of a urinary tract infection (UTI) can include cloudy or bloody urine that may smell strongly or filthy, low-grade fever in certain cases, pain or burning when urinating, pressure or cramping in the lower abdomen or back, an intense urge to urinate frequently, and more.

As per the research studies, the second most prevalent infectious disease, urinary tract infections (UTIs), impacts more than 150 million people worldwide each year.

The 2023 data published by NHS England mentioned that over 1.8 million hospital admissions with UTIs occurred between 2018–19 and 2022–2023; most of the patients were 65 years of age or older.

As per the above-mentioned source of the 147,285 admissions with a main diagnosis of UTI in the previous year (2022–2023), 56% (82,392) were for patients over 65, with the highest number being in the 80–84 age range (17,280 admissions).

The Kidney Foundation 2020 also stated that an estimated 500,000 healthcare visits by Canadian women were brought on by UTIs annually.

The Kidney Research UK even mentioned that in the UK, an estimated 50% of women had experienced a urinary tract infection.

Therefore, the increasing patient population suffering from urinary tract infections globally is thereby anticipated to propel the overall market growth of the urinary tract infection testing market during the forecast period from 2024 – 2030.

However, limited access to urinary tract infection testing products and services, particularly in low-income countries, and poor diagnostic efficacy of urinary tract infection testing products leading to faulty results may restrict the growth of the overall urinary tract infection testing market.

Urinary Tract Infection Testing Market Segment Analysis:

Urinary Tract Infection Testing Market By Test Type (Urinalysis, Urine Cultures, and Susceptibility Testing), Product Type (Instruments and Kits [Laboratory Test Kits and Home Test Kits), End-User (Hospitals, Diagnostic Labs, and Others), And Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment under the kits category of the urinary tract infection testing market, the home test kits, category is expected to amass a significant revenue share in the year 2023.

The rising cases of urinary tract infections globally and growing preference for at-home and self-testing for early diagnosis of urinary tract infections are likely to accelerate the segmental market growth.

The at-home urinary tract infection testing kits can detect the presence of urinary tract infections in the comfort of own home efficiently and accurately.

Urinary tract infection testing using home-based test kits can be done easily by just immersing a dipstick or strip in a urine simple. The results of the tests are available within minutes.

The home test kits eliminate the need to go to hospitals or diagnostic labs to get tested for urinary tract infections and wait for 24 hours or more for results.

The home test kits are available in a convenient packing and allow one to monitor one’s urinary health over time.

With these home test kits, one can take control of their health and can take proactive steps to prevent potential infections in the future.

For example, the i-know UTI testing kit is an accurate and convenient solution for those who want to test UTI in the comfort of their own home. The kit detects the presence of leukocytes and nitrites in your urine, which are key indicators of a UTI. It also provides quick and accurate results in just 2 minutes.

Thus, all the above-mentioned factors are likely to propel the market for home test kits in urinary tract infection testing. 

North America is expected to dominate the overall Urinary Tract Infection Testing Market:

Among all the regions, North America is estimated to account for the largest share of the urinary tract infection testing market in the year 2023. This domination is due to factors such as the increasing prevalence of urinary tract infection and its risk factors Furthermore, the increasing healthcare expenditure, rising research and development activities in the region, and surging launch and approval of new products are also driving the market growth of urinary tract infection testing in the United States.

As per the fact mentioned by the National Healthcare Safety Network (NHSN), urinary tract infections (UTIs) are the most common type of healthcare-associated infection in the US. The same source stated that among UTIs acquired in the hospital, approximately 75% are associated with a urinary catheter, which is a tube inserted into the bladder through the urethra to drain urine. It is concerning because about 15-25% of hospitalized patients receive urinary catheters during their hospital stay in the US as stated by the same source.

The Data from the Centers for Disease Control and Prevention (CDC) & the Emerging Infections Program (EIP) 2019 based upon Point Prevalence Survey of Healthcare Associated Infection (HAI) and Antimicrobial Use (AU) in US nursing homes: Urinary Tract Infections (UTI), the prevalence rate for urinary tract infection was 0.48 per 100 residents in 2019 and out of this 80% cases were Symptomatic UTI and 20% were Catheter associated-Symptomatic UTI.

Also, the rise in product development activities is going to accelerate the regional market growth. For example, in March 2019, the US FDA approved a smartphone-based urinalysis test kit for at-home use that matches the quality of clinical laboratory tests.

Moreover, as per the US Department of Health and Human Services (HHS) press release in the year 2021, the US government had invested USD 650 million in rapid diagnostic testing in the latest action to increase access to tests.

Thus, all the above mentioned factors are likely to increase the market for Urinary Tract Infection Testing in the region during the forthcoming years.

Urinary Tract Infection Testing Market Key Players:

Some of the key market players operating in the urinary tract infection testing market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, ACON Laboratories, Inc., Cardinal Health, Sysmex Corporation, Abbott, Siemens Healthcare Private Limited, Laboratory Corporation of America® Holdings, Randox Laboratories Ltd., Vivoo, QIAGEN, bioMérieux SA, PIRAMAL PHARMA LIMITED, Healthy.io, and Others.

Recent Developmental Activities in the Urinary Tract Infection Testing Market:

• In January 2024, Vivoo, a wellness app providing personalized nutrition and lifestyle advice based on at-home urine tests, launched its at-home digital Urinary Tract Infection (UTI) testing product at CES 2024.

Key Takeaways from the Urinary Tract Infection Testing Market Report Study

• Market size analysis for current urinary tract infection testing market size (2023), and market forecast for 6 years (2024-2030)
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global urinary tract infection testing market.
• Various opportunities available for the other competitors in the urinary tract infection testing market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current urinary tract infection testing market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for urinary tract infection testing market growth in the coming future?

Target Audience who can be benefited from this Urinary Tract Infection Testing Market Report Study

• Urinary Tract Infection Testing product providers
• Research organizations and consulting companies
• Urinary Tract Infection Testing-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Urinary Tract Infection Testing
• Various End-Users who want to know more about the urinary tract infection testing market and the latest developments in the urinary tract infection testing market.

Frequently Asked Questions for the Urinary Tract Infection Testing Market:

1. What is a urinary tract infection (UTI)?

A urinary tract infection, or UTI, is an infection in any part of the urinary system, which includes the kidneys, bladder, ureters, and urethra.

2. What is the market for global urinary tract infection testing?

The global urinary tract infection testing market was valued at USD 607.20 million in 2023, growing at a CAGR of 5.67% during the forecast period from 2024 to 2030 to reach USD 893.11 million by 2030.

3. What are the drivers for the global urinary tract infection testing market?

The demand for urinary tract infection testing is primarily being boosted by the rising number of cases of urinary tract infections (UTI) globally, the growing incidence of hospital-acquired urinary tract infection, and increasing preference for at-home and self-testing kits for early diagnosis of UTI among others. Furthermore, the urinary tract infection testing market is anticipated to grow on account of a large number of ongoing research activities in this field, collaborations between healthcare providers, researchers, and industry players, and strategic partnerships among others are going to contribute to the overall growth of the urinary tract infection testing market during the forecast period from 2024-2030.

4. Who are the key players operating in the global urinary tract infection testing market?

Some of the key market players operating in the urinary tract infection testing market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, ACON Laboratories, Inc., Cardinal Health, Sysmex Corporation, Abbott, Siemens Healthcare Private Limited, Laboratory Corporation of America® Holdings, Randox Laboratories Ltd., Vivoo, QIAGEN, bioMérieux SA, PIRAMAL PHARMA LIMITED, Healthy.io, and Others.

5. Which region has the highest share in the urinary tract infection testing market?

North America is expected to dominate the overall urinary tract infection testing market during the forecast period from 2024-2030. Owing to the significance of key growth factors such as the increasing prevalence of urinary tract infection and its risk factors Furthermore, the increasing healthcare expenditure, rising research and development activities in the region, and surging launch and approval of new products are also driving the market growth of urinary tract infection testing in the United States.